Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05474768
Other study ID # 2021PI221
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 2, 2022
Est. completion date January 2023

Study information

Verified date July 2022
Source Central Hospital, Nancy, France
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Hormonal treatment of gender dysphoria can have repercussions on metabolism, cardiovascular system and fertility and represents à potential oncological risk. According to the recommendations of the Endocrine society. Therefore, initial assessment and follow-up visits are necessary and must be carried out to avoid the apparition of potentially undesirable effects.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date January 2023
Est. primary completion date November 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - being a parent of adolescent/child presenting Gender dysphoria - adult subject (age > 18 years) presenting Gender dysphoria non-inclusion criteria - Severe, uncontrolled psychiatric or somatic illness - Chronic alcoholism - Substance abuse - Refusal or linguistic, physical or psychological incapacity to participate in the study - Ongoing pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Other:
no intervention
no intervention

Locations

Country Name City State
France CHRU de Nancy Nancy

Sponsors (1)

Lead Sponsor Collaborator
Central Hospital, Nancy, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Describe expectations and beliefs of transgener people about hormonal therapy qualitative analysis of qualitative data from collective discussions (focus groups) 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT06093724 - Prospective Imaging Assessment of Perineo-pelvic Static's Evolution After Sexual Reassignment Surgery in MtF Transgender Patient, by Peno-scrotal Inversion Vaginoplasty Technique (TRANSPELV) N/A
Recruiting NCT04977765 - Cardiometabolic Health in Transgender Males
Recruiting NCT06074796 - The Determinants of Fertility Preservation in TRANSgender Patients.
Completed NCT04454970 - Safe Access for Bladder Entry in Transgender Men Following Penile Reconstruction N/A
Completed NCT04708600 - Effectiveness of Speech Therapy in Trans Women. N/A
Terminated NCT04551144 - Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors
Completed NCT04545450 - Effects of Testosterone Plus Dutasteride or Placebo on Muscle Strength, Body Composition and Metabolism in Transmen Phase 3
Recruiting NCT05663892 - Drug-Drug Interaction Study in Trans Women Living With HIV Phase 4
Completed NCT05666102 - Transgender Men's Perspectives on HIV Risk and HIV Prevention Interventions N/A
Recruiting NCT04838249 - Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System
Not yet recruiting NCT06434805 - An Education Initiative to Reduce Stigma Towards Sex Workers and Sexual Minorities Among Nursing Students N/A
Recruiting NCT05883553 - Epithesis Versus Prosthesis in Post-phalloplasty Transgender Patients. N/A
Not yet recruiting NCT04154358 - Implementing HPV DNA Self-Collection to Increase Rates of Cervical Cancer Screening in Transgender Men N/A
Recruiting NCT04254354 - Transgender Men, Non-binary Persons and Testosterone Treatment BODY IDENTITY CLINIC
Completed NCT04969003 - Reducing Transphobia Among Adolescents Through a Brief Video Intervention N/A
Completed NCT06149065 - Factors Associated With the Acne Severity Among Transmen Population: a Cross-sectional Study
Not yet recruiting NCT06443164 - Efficacy of a Chronic Pain Treatment Prior to Gender-affirming Surgery N/A
Not yet recruiting NCT06450405 - Androgen Effects on the Reproductive Neuroendocrine Axis
Terminated NCT04275310 - Microeconomic Intervention to Reduce HIV Transmission in Economically Disadvantaged Transgender Women N/A
Not yet recruiting NCT05415930 - Evaluation of an Adaptative, Multidisciplinary, Reach-out Program, Facilitating Pre Exposition HIV Prophylaxis (PrEP) Prescription and Retention in Care, in a Group of Trans Womens (TW) at High Risk of HIV Infection.